Ekterly® (sebetralstat)
for Hereditary Angioedema

Ekterly (sebetralstat) is a plasma kallikrein inhibitor used to treat acute hereditary angioedema (HAE) attacks in patients aged 12 and older. It works by blocking kallikrein, an enzyme involved in blood vessel dilation and fluid leakage. This reduces bradykinin levels, helping prevent the swelling associated with HAE attacks.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hereditary Angioedema - HAE